FDA Approves Novel Pain Pill Without Addiction Risk

(MedPage Today) -- The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, the agency announced Thursday.
"Today's approval is an important...